Atlas Trials

A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-H3733 in Subjects With Chronic Hepatitis B Virus Infection

Clinical trial NCT05414981 · COMPLETED

Trial details

NCT number
NCT05414981
Sponsor
Assembly Biosciences
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Chronic Hepatitis B
Start date
2022-08-07
Primary completion
2023-04-24
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.